SEC Form 4 · accession 0001209191-19-010650
CHIASMA, INC · CHMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Ludlam
Officer — See Remarks
Period of report
Feb 14, 2019
Accepted (ET)
Feb 15, 2019 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339469
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.75 | Feb 14, 2019 | A | 70,000 | A | — | Feb 14, 2029 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1The shares of Common Stock underlying the option will vest in quarterly installments over 4 years from the date of grant.
Remarks
: Title: Senior Vice President, Clinical and Medical Affairs